Puma Biotechnology | PBYI - Market Capitalization


Puma Biotechnology reported $363M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.57B 290M May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 12.9B 1.15B May/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 21.73B 3B May/2026
MacroGenics USD 102M 4M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 148.08B 6.51B May/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.04B 176M May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Vertex Pharmaceuticals USD 111.03B 2.55B May/2026